Study to Evaluate Efficacy and Safety of Oral Doses of Hyoscine Butylbromide for the Treatment of Occasional Abdominal Pain, Cramping, and Discomfort
Clinical trial NCT02242292 · COMPLETED
Trial details
- NCT number
- NCT02242292
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-04-01
- Primary completion
- 2007-01-01
- Enrollment
- 527
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.